ArticleBlood2016

4EBP1/c-MYC/PUMA and NF-κB/EGR1/BIM pathways underlie cytotoxicity of mTOR dual inhibitors in malignant lymphoid cells.

Seongseok Yun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.